Importance of prognostic factors in the treatment of CLL and how to assess them
Copanlisib produces promising results in relapsed/refractory follicular lymphoma
How can we overcome ibrutinib resistance?
The impact of the clinical trial of venetoclax (ABT-199) and obinutuzumab in CLL
'Off the shelf' virus-specific T cells